Ramon Varcoe, Prince of Wales Hospital, Sydney, New South Wales, Australia and colleagues published the clinical and imaging outcomes obtained when they investigated a new bioresorbable vascular scaffold (Absorb, Abbott Vascular) for the treatment of focal tibial and distal popliteal lesions in the Journal of Endovascular Therapy (JEVT) in April 2015. They subsequently presented their first experience with the everolimus-eluting, bioresorbable scaffold for use in peripheral arteries below the knee at EUROPCR in Paris, France. The study was also published in EuroIntervention.
The first US commercial case using Silk Road Medical’s Enroute transcarotid stent system has been successfully performed at Kaiser Permanente Moanalua Medical Center in Honolulu, Hawaii, by vascular surgeon Peter A Schneider. The Enroute transcarotid stent is designed specifically for transcarotid artery revascularisation (TCAR), combining the surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke.
InspireMD announced the full market launch of the CGuard Embolic Prevention System for the treatment of carotid artery disease by its strategic distribution partner, Penumbra, at the CIRSE Annual Congress (26–30 September, Lisbon, Portugal). Penumbra leverages its direct European commercialisation team to launch CGuard distributed by Penumbra.
Gerard O’Sullivan announced preliminary results from a European study of venous stents at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2015 meeting (26–30 September, Lisbon, Portugal). O’Sullivan is the principal investigator of the VIVO-EU study at the University Hospital Galway, Ireland.
The trial’s results were published in JACC: Cardiovascular Interventions and show no intracranial haemorrhage and no death among massive pulmonary embolism patients.
Medtronic has announced favourable five-year data in the VALOR II study, demonstrating the durability of the Valiant thoracic stent graft system, an innovative and minimally invasive treatment for patients with thoracic aortic aneurysms (TAA).
The first US commercial case using Silk Road Medical’s Enroute transcarotid stent system has been successfully performed at Kaiser Permanente Moanalua Medical Center in Honolulu, Hawaii, by vascular surgeon Peter A Schneider. The Enroute transcarotid stent is designed specifically for transcarotid artery revascularisation (TCAR), combining the surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke.
The US Food and Drug Administration has granted conditional approval for a US and European Investigational Device Exemption (IDE) clinical trial to investigate the use of the Intact Vascular’s Tack Endovascular System as a dissection repair therapy in patients with peripheral arterial disease undergoing percutaneous angioplasty.
Researchers at Queen Mary University of London (QMUL) have developed a way of assembling organic molecules into complex tubular tissue-like structures without the use of moulds or techniques like 3D printing.
The use of a wearable exercise tracker can improve walking distance and quality of life in patients suffering from intermittent claudication at six months, a study has shown. Results of the randomised wSTEP (Wearable sensor technology efficacy in peripheral vascular disease) trial were presented at the British Society of Endovascular Therapy Annual Meeting (BSET; 2–3 July, Walton Hall, UK).
New 12-month clinical trial outcomes assessing the safety and performance of the Eluvia drug-eluting vascular stent system (Boston Scientific) reflect a primary patency rate of more than 96%.
Bolton Medical has received the CE mark for the Treo abdominal stent graft system used to treat abdominal aortic aneurysms (AAAs).
A new peer reviewed article e-published in the Journal of Vascular Surgery highlights the clinical benefits of treating patients with Lombard Medical’s Aorfix endovascular stent graft.
Early experience with a device that allows the preservation of the hypogastric artery during endovascular treatment of iliac artery aneurysms shows that the endograft is safe and effective, with a high success rate and patency of over 90% at six months. Results with the new Iliac Branch Excluder were presented at the Vascular Annual Meeting (17–20 June, Chicago, USA).
A new study shows that positron emission tomography-computed tomography (PET-CT) can be performed in peripheral arteries “with strong reliability”, according to the investigators. They say also that their results may provide early evidence of possible links between calcification and inflammatory processes occurring within the lower limb arterial tree.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos